Selective induction of the coumarin hydroxylase by N-containing heteroaromatic compounds.
Hahnemann
B
B
Department of Pharmacology and Toxicology, Philipps-University Marburg, F.R.G.
Kühn
B
B
Heubel
F
F
Legrum
W
W
D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases; D065637:Cytochrome P-450 CYP2A6; D004790:Enzyme Induction / Q000187:drug effects; D005036:Ethylmorphine / Q000378:metabolism; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D006899:Mixed Function Oxygenases / Q000096:biosynthesis*; D010078:Oxazines / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D013329:Structure-Activity Relationship
D006571:Heterocyclic Compounds; D007093:Imidazoles; D010078:Oxazines; D011720:Pyrazoles; D011725:Pyridines; D008748:Methylcholanthrene; C007649:ethoxyresorufin; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; D065637:Cytochrome P-450 CYP2A6; D005036:Ethylmorphine; D010634:Phenobarbital